EXCLUSIVE: Avalon GloboCare Tells Benzinga Co Announces Its Subsidiary aboratory Services MSO, LLC Is Now Offering An In-House Laboratory Developed Test ("LDT") To Detect Tuberculosis ("TB") Using A Patient's Sputum Aample
Portfolio Pulse from Benzinga Newsdesk
Avalon GloboCare's subsidiary, Laboratory Services MSO, LLC, has announced that it is now offering an in-house laboratory developed test to detect Tuberculosis using a patient's sputum sample.
August 30, 2023 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Avalon GloboCare's new in-house Tuberculosis test could potentially increase the company's revenue and market share in the healthcare sector.
The introduction of a new in-house Tuberculosis test by Avalon GloboCare's subsidiary could potentially increase the company's revenue as it expands its product offerings. This could also increase the company's market share in the healthcare sector, as it provides a new service that could be in high demand due to the prevalence of Tuberculosis. Therefore, this news is likely to have a positive impact on the company's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100